| pubmed-article:1797498 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1797498 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:1797498 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:1797498 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
| pubmed-article:1797498 | lifeskim:mentions | umls-concept:C0011854 | lld:lifeskim |
| pubmed-article:1797498 | lifeskim:mentions | umls-concept:C0021641 | lld:lifeskim |
| pubmed-article:1797498 | lifeskim:mentions | umls-concept:C0020258 | lld:lifeskim |
| pubmed-article:1797498 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:1797498 | lifeskim:mentions | umls-concept:C2699739 | lld:lifeskim |
| pubmed-article:1797498 | lifeskim:mentions | umls-concept:C1549040 | lld:lifeskim |
| pubmed-article:1797498 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:1797498 | pubmed:dateCreated | 1992-4-16 | lld:pubmed |
| pubmed-article:1797498 | pubmed:abstractText | Fasting hyperglycemia is common in patients with insulin-dependent diabetes mellitus (IDDM) treated with twice-daily subcutaneous insulin regimens. We postulated that substituting human ultralente insulin for the presupper dose of intermediate-acting insulin would improve overnight glycemic control in children and adolescents with IDDM. | lld:pubmed |
| pubmed-article:1797498 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1797498 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1797498 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1797498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1797498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1797498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1797498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1797498 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1797498 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1797498 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:1797498 | pubmed:issn | 0149-5992 | lld:pubmed |
| pubmed-article:1797498 | pubmed:author | pubmed-author:WolfsdorfJ... | lld:pubmed |
| pubmed-article:1797498 | pubmed:author | pubmed-author:VernonAA | lld:pubmed |
| pubmed-article:1797498 | pubmed:author | pubmed-author:LaffelL MLM | lld:pubmed |
| pubmed-article:1797498 | pubmed:author | pubmed-author:HerskowitzR... | lld:pubmed |
| pubmed-article:1797498 | pubmed:author | pubmed-author:PasquarelloCC | lld:pubmed |
| pubmed-article:1797498 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1797498 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:1797498 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1797498 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1797498 | pubmed:pagination | 1100-6 | lld:pubmed |
| pubmed-article:1797498 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:meshHeading | pubmed-meshheading:1797498-... | lld:pubmed |
| pubmed-article:1797498 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1797498 | pubmed:articleTitle | Split-mixed insulin regimen with human ultralente before supper and NPH (isophane) before breakfast in children and adolescents with IDDM. | lld:pubmed |
| pubmed-article:1797498 | pubmed:affiliation | Department of Pediatrics, Joslin Diabetes Center, Boston, MA. | lld:pubmed |
| pubmed-article:1797498 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1797498 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1797498 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:1797498 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:1797498 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
